An outbreak of serogroup C meningococcal disease in the province of Antwerp (Belgium) in 2001-2002

European Journal of Epidemiology

Volumn 18, Issue 11, 2003, Pages 1073-1077

  De Schrijver, Koen ^a,c   Maes, Inge ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Flemish Health Inspectorate   (Belgium)

^c NONE   (Belgium)

Author keywords

Meningococcal disease; Outbreak investigation; Surveillance and control; Vaccination

Indexed keywords

MENINGOCOCCUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; BELGIUM; CHILD; EPIDEMIC; HUMAN; INCIDENCE; INFANT; INFECTION CONTROL; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PHENOTYPE; SEROTYPE; VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BELGIUM; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; INFANT, NEWBORN; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; MIDDLE AGED; NEISSERIA MENINGITIDIS, SEROGROUP B; NEISSERIA MENINGITIDIS, SEROGROUP C; SENTINEL SURVEILLANCE; SEPSIS; TIME;

EID: 0242301056     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026100321871     Document Type: Article

References (15)

1. Swartz B, Moore PS, Broome CV. The global epidemiology of meningococcal diseases. Clin Micrbiol Rev 1989; 2: S11S-S124.
2. Van Looveren M, Carion F, Van Damme P, Goossens H. Surveillance of meningococcal infections in Belgium. Clin Microbiol Infect 1998; 4: 224-228.
3. Van Looveren M, Caugant DA, Chapelle S, Carion F, Goossens H. Interpreting the rising incidence of meningococcal disease in Belgium: The contribution of molecular typing. J Med Microbiol 2001; 50: 986-990.
4. Carion F, Van Looveren M, Goossens H. New epidemiolgical features of meningococcal disease in Belgium. Eurosurveill Monthly 1997; 10: 80.
5. Carion F. Annual report of N. meningitidis reference laboratory, Belgium 2001. Institute of Public Health, Brussels, 2002; pp. 1-10.
6. Maes I, De Schrijver K. Het komen en gaan van een meningokokkenepidemie. Epidemiologisch Bulletin van de Vlaamse Gemeenschap 2002; 2: 20-24.
7. Top G. Registratie van infectieziekten Vlaamse gezondheidsinspectie 2000-2002. Brussel, 2002.
8. Samuelsson S. Meningococcal disease - still a major challenge. Commun Dis Public Health 2002; 5(3): 78-81.
9. Davison KL, Ramsay ME, Crowcroft NS, et al. Estimating the burden of serogroup C meningococcal disease in England and Wales. Commun Dis Public Health 2002; 5(2): 213-219.
10. Hubert B, Caugant DA. Recent changes in meningococcal disease in Europe. Eurosurveill Monthly 1997; 10: 69-71.
11. Tyrell GJ, Chui L, Johnson M, et al. Outbreak of Neisseria meningitidis, Edmonton, Alberta, Canada. Emerg Infect Dis 2002; 8, url www.cdc.gov/ncidod/ EID/vol8no7/02-0157htm.
12. CDSC. Vaccination programme for C meningoccal infection is launched. Commun Dis Rep CDR Wkl 1999; 9: 261-264.
13. Maiden MCJ, Stuart JM for the UK Meningococcal Carriage Group. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 2002; 359: 1829-1830.
14. Alcalá B, Arreaza L, Salcedo C, Uria MJ, De la Fuente L, Vázquez. Capsule Switching among C:2b:P1.2,5 Meningococcal Epidemic Strains after Mass Immunization Campaign, Spain. Emerg Infect Dis 2002; 8: 1512-1514.
15. Krause G, Blackmore C, Wirsma S, Lesneski C, Gauch L, Hopkins RS. Mass Vaccination campaign Following Community outbreak of Meningococcal Disease. Emerg Infect Dis 2002; 8: 1398-1403.